IP Library Granted Patent US 7,071,356
Granted Patent B1
US 7,071,356 · App. 11/291,604 · Granted Jul 4, 2006

Process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid

Assignee: ISP Investments Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,071,356
App. No.
11/291,604
Granted
Jul 4, 2006
Kind
B1
Abstract

A method of producing gabapentin (1-amino-methyl)-1-cyclohexaneacetic acid) from its hydrochloric salt in an anhydrous medium, the method consisting of: dissolving gabapentin hydrochloride in a non-aqueous organic solvent in which gabapentin is insoluble to obtain a solution of gabapentin hydrochloride; adding an epoxide to the solution to remove the chloride ions thereby precipitating gabapentin out of the solution as a white solid; recovering the white solid by filtration; and drying the white solid.

Claims (12)

1. A process for the preparation of gabapentin from gabapentin hydrochloride comprising:

dissolving gabapentin hydrochloride in a non-aqueous organic solvent to obtain a solution;

adding an epoxide to the solution to remove the chloride ions from the solution thereby precipitating gabapentin out of the solution as a white solid in its free amino acid form;

recovering the white solid by filtration; and

drying the white solid until no loss of weight is observed.

2. The process of claim 1 wherein the gabapentin hydrochloride is soluble in the solvent while the gabapentin is not soluble therein.

3. The process according to claim 1 wherein said non-aqueous organic solvent is selected from the group consisting of: methanol, ethanol, isopropyl alcohol and n-butanol.

4. The process of claim 1 wherein said epoxide is selected from the group consisting of ethylene oxide, 1,2-epoxybutane, and propylene oxide.

5. The process of claim 1 wherein said hydrochloride reacts with said oxide opens up the ring in the molecule and releases the gabapentin in its free amino acid form.

6. The process of claim 1 wherein the reaction of said oxide and said hydrochloride is carried out at a temperature of about 0°–50° C.

7. The process of claim 6 wherein said reaction is carried out at about 10°–25° C.

8. The process of claim 1 wherein said dried solid of gabapentin is at least about 99.0% pure.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 22, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042521/0083 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
PATENT RELEASE Recorded Sep 19, 2011
From: JPMORGAN CHASE BANK, N.A. (F/K/A THE CHASE MANHATTAN BANK)
To: ISP CAPITAL, INC.; ISP CHEMICAL PRODUCTS, INC.; VERONA, INC.
Reel/Frame 026930/0774 →
SECURITY AGREEMENT Recorded Sep 16, 2011
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; HERCULES INCORPORATED; AQUALON COMPANY; ISP INVESTMENT INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 026918/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2005
From: NIGAM, SATISH C.; NACHARAJU, KRISHNAMURTHY; BURON, CHRISTOPHE
To: ISP INVESTMENS INCO
Reel/Frame 017316/0940 →